immunoreactive insulin ( iri ) and c-peptide secretory responses to consecutive stimulations with terbutaline , glucagon , glucose and a standard meal were investigated in fasted subjects with newly diagnosed , untreated type 2 diabetes with and without concomitant administration of the sulphonylurea agent glipizide ( 5 mg ) .
C0011860
type 2 diabetes
C0017642
glipizide